Theodore Rogers
Family Medicine · Perryville, MONPI 1699111781
Payments from drug & device makers
Across 353 payments — averaging $19.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Lilly USA, LLC$698
- Novo Nordisk$355
- Amgen$306
- Novartis$302
- Bayer$241
- plus $2K from 28 others
What the payments were for
- Food & beverage$6,720100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 139 | $3,114 |
| Lilly USA, LLC | 43 | $698 |
| Novo Nordisk | 19 | $355 |
| Amgen | 19 | $306 |
| Novartis | 14 | $302 |
| Bayer | 13 | $241 |
| Boehringer Ingelheim | 14 | $218 |
| Otsuka America Pharmaceutical, Inc. | 8 | $164 |
| GSK | 10 | $142 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $123 |
| Merck | 7 | $113 |
| Johnson & Johnson | 7 | $106 |
| AstraZeneca | 7 | $106 |
| Organon | 6 | $76 |
| Sunovion Pharmaceuticals Inc. | 5 | $76 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $68 |
| Astellas Pharma US Inc | 4 | $63 |
| Pfizer | 4 | $60 |
| Amarin Pharma, Inc. | 3 | $52 |
| Exact Sciences | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Dexcom, Inc. | 2 | $33 |
| Eisai Inc. | 2 | $32 |
| Abbott | 2 | $29 |
| Exeltis, USA Inc. | 2 | $27 |
| Medtronic | 1 | $22 |
| Optumhealth Care Solutions, LLC | 1 | $22 |
| Lundbeck LLC | 1 | $16 |
| Viatris Specialty LLC | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Mylan Specialty L.p. | 1 | $11 |
How this compares
$6,720 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 50 | $77,998 |
| EliquisApixaban | 155 | $66,143 |
| JardianceEmpagliflozin | 37 | $33,099 |
| TrulicityDulaglutide | 29 | $30,512 |
| RybelsusSemaglutide | 16 | $26,947 |
| FarxigaDapagliflozin Propanediol | 28 | $23,875 |
| LinzessLinaclotide | 41 | $23,322 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $22,286 |
| MounjaroTirzepatide | 17 | $21,527 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $12,826 |
| JanuviaSitagliptin Phosphate | 18 | $12,556 |
| TradjentaLinagliptin | 15 | $11,140 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 33 | $9,829 |
| MyrbetriqMirabegron | 20 | $9,739 |
| XareltoRivaroxaban | 17 | $8,189 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $355 | $104,94566 claims |
| PfizerEliquis | $60 | $66,143155 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $698 | $52,03946 claims |
| Boehringer IngelheimJardiance, Tradjenta | $218 | $44,23952 claims |
| GSKTrelegy Ellipta, Arexvy | $142 | $32,11567 claims |
| AstraZenecaFarxiga | $106 | $23,87528 claims |
| AbbVieLinzess | $3,114 | $23,32241 claims |
| MerckJanuvia | $113 | $12,55618 claims |
| Astellas Pharma US IncMyrbetriq | $63 | $9,73920 claims |
| Johnson & JohnsonXarelto | $106 | $8,18917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Perryville
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.